Cover Image

How to manage KRAS G12C-mutated advanced non-small-cell lung cancer

Constitutive KRAS signalling drives tumorigenesis across several cancer types. In non-small-cell lung cancer (NSCLC) activating KRAS mutations occur in ~30% of cases, and the glycine to cysteine substitution at codon 12 (G12C) is the most common KRAS alteration. Although KRAS mutations have been con...

Full description

Saved in:

Bibliographic Details
Main Authors:	Biagio Ricciuti (Author), Alessia Mira (Author), Elisa Andrini (Author), Pietro Scaparone (Author), Sandra Vietti Michelina (Author), Federica Pecci (Author), Luca Cantini (Author), Andrea De Giglio (Author), Giuseppe Lamberti (Author), Chiara Ambrogio (Author), Giulio Metro (Author)
Format:	Book
Published:	BioExcel Publishing Ltd, 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Non-small-cell lung cancer: how to manage EGFR-mutated disease
by: Federica Pecci, et al.
Published: (2022)

Non-small-cell lung cancer: how to manage RET-positive disease
by: Elisa Andrini, et al.
Published: (2022)

Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease
by: Giulio Metro, et al.
Published: (2022)

The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks
by: Andrea De Giglio, et al.
Published: (2023)

Advanced non-small-cell lung cancer: how to manage non-oncogene disease Andrea De Giglio, Alessandro Di Federico, Chiara De
by: Andrea De Giglio, et al.
Published: (2022)

Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease
by: Daniele Marinelli, et al.
Published: (2022)

TEAD Inhibitors Sensitize KRAS<sup>G12C</sup> Inhibitors via Dual Cell Cycle Arrest in KRAS<sup>G12C</sup>-Mutant NSCLC
by: Salvina Laura Tammaccaro, et al.
Published: (2023)

Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer
by: Eszter Molnár, et al.
Published: (2024)

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
by: Alice Indini, et al.
Published: (2021)

Kras: trajnostni razvoj kraške pokrajine
Published: (2008)

Targeting the untargetable KRAS in cancer therapy
by: Pingyu Liu, et al.
Published: (2019)

KRAS mutations and endometriosis burden of disease
by: Natasha L Orr, et al.
Published: (2023)

The KRAS key to modelling childhood sarcoma
Published: (2022)

Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer Cells
by: Xing-Duo Dong, et al.
Published: (2022)

Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer
by: Masayuki Hiraki, et al.
Published: (2015)

Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients
by: Si-Yang Liu, et al.
Published: (2020)

TCR-mimic antibody-drug conjugates targeting intracellular tumor-specific mutant antigen KRAS G12V mutation
by: Ying Shen, et al.
Published: (2020)

Virtual Screening Based on Machine Learning Explores Mangrove Natural Products as KRAS<sup>G12C</sup> Inhibitors
by: Lianxiang Luo, et al.
Published: (2022)

Targeting mutated KRAS in the first‐line therapy
by: Hideaki Ijichi
Published: (2024)

KRAS-associated microRNAs in colorectal cancer
by: Hamizah Ibrahim, et al.
Published: (2020)

In silico analysis of wild-type and mutant KRAS
by: Frengki Frengki, et al.
Published: (2019)

Activity of sotorasib against brain metastases from NSCLC harboring KRAS p.G12C mutation: a case report
by: Alessandro Inno, et al.
Published: (2023)

First-line alectinib for ALK-positive lung cancer: is there room for further improvement?
by: Alfredo Addeo, et al.
Published: (2018)

Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig
by: Pinaki Mondal, et al.
Published: (2023)

A comparability study of 5 commercial <it>KRAS </it>tests
by: Gyuris Tibor, et al.
Published: (2010)

A real-world pharmacovigilance study of KRAS G12C mutation inhibitors based on the food and drug administration adverse event reporting system
by: Lisha Wu, et al.
Published: (2024)

Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case report
by: Tillmann Bedau, et al.
Published: (2024)

KRAS and BRAF Mutation in Borderline Epithelial Type Ovarian Tumor
by: Dodi Suardi
Published: (2013)

Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC
by: Luca Cantini, et al.
Published: (2021)

Optical Super-High Magnification Dermoscopy: A Complementary Means in the Diagnosis of Trombiculosis
by: Corinne Orsini, et al.
Published: (2023)

The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers
by: Hamada A. Mokhlis, et al.
Published: (2019)

KRAS and the Reality of Personalized Medicine in Non-Small Cell Lung Cancer
by: Havva O Kilgoz, et al.
Published: (2016)

Results-based management - Developing one's key results areas (KRAs)
by: Om Prakash Kansal, et al.
Published: (2015)

Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
by: Eiichi Sasaki, et al.
Published: (2020)

KRAS Codon 12 and 13 Mutations in Gastric Cancer in the Northeast Iran
by: Hossein Ayatollahi, et al.
Published: (2018)

Synergy of GSK-J4 With Doxorubicin in KRAS-Mutant Anaplastic Thyroid Cancer
by: Bo Lin, et al.
Published: (2020)

Kras Diagnosing the Little-Known Cancers Oncogene through Liquid Biopsy: Review
by: Hafiz Syed Mohammad Osama Jafri, et al.
Published: (2020)

YRDC Mediates the Resistance of Lenvatinib in Hepatocarcinoma Cells via Modulating the Translation of KRAS
by: Jun Guo, et al.
Published: (2021)

Pancreatic Ductal Organoids React Kras Dependent to the Removal of Tumor Suppressive Roadblocks
by: Lukas Perkhofer, et al.
Published: (2019)

HUBUNGAN ANTARA PERSEPSI TERHADAP KEPEMIMPINAN PEREMPUAN DENGAN MOTIVASI MENGEMBANGKAN KARIR
by: Kustampinutri , Andrini
Published: (2011)